IBJNews

Lilly to let 115 workers go in new outsourcing deal

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. will trim another 115 jobs from its work force but hopes to keep those employees working in exactly the same place they are now.

The Indianapolis-based drugmaker announced a five-year deal this morning with Massachusetts-based Thermo Fisher Scientific to take on duties to manufacture, package and label the products Lilly uses in its clinical trials of experimental drugs.

That work is and will continue to be done in the northern part of the Lilly Technology Center, located South Harding Street south of downtown Indianapolis. However, Thermo Fisher’s subsidiary, Fisher Clinical Services, has agreed to purchase from Lilly the equipment it uses to do that work.

Financial terms of the deal were not disclosed.

All affected Lilly employees can apply for jobs with Fisher, according to the companies, although they did not disclose how many Fisher planned to hire.

Of the affected employees, 80 are full-time workers, which means they can apply for other internal openings at Lilly or take a severance.

Another 20 of the workers have fixed-duration employment contracts and a further 15 are contractors. They, too, can apply with Fisher but will not receive any severance from Lilly.

Fisher will make its decisions about hiring Lilly workers in about three weeks, said Lilly spokeswoman Christine Van Marter.

Lilly has been outsourcing an increasing amount of work and trimming its staff accordingly. The company’s payroll has shrunk to nearly 40,000, down from 46,000 six years ago, even though the Lilly acquired ImClone Systems Inc. and several smaller companies.

In September, Lilly announced a two-year plan to cut its workforce by 5,500 people.

"Transitioning work like the manufacturing, packaging and labeling of clinical trial materials to Fisher Clinical Services helps us also reach Lilly's corporate goals of reducing the costs of drug development and speeding innovative medicines to patients,” said Ralph Lipp, vice president of pharmaceutical sciences research and development for Lilly, in a statement.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. I am also a "vet" of several Cirque shows and this one left me flat. It didn't have the amount of acrobatic stunts as the others that I have seen. I am still glad that I went to it and look forward to the next one but I put Varekai as my least favorite.

  2. Looking at the two companies - in spite of their relative size to one another -- Ricker's image is (by all accounts) pretty solid and reputable. Their locations are clean, employees are friendly and the products they offer are reasonably priced. By contrast, BP locations are all over the place and their reputation is poor, especially when you consider this is the same "company" whose disastrous oil spill and their response was nothing short of irresponsible should tell you a lot. The fact you also have people who are experienced in franchising saying their system/strategy is flawed is a good indication that another "spill" has occurred and it's the AM-PM/Ricker's customers/company that are having to deal with it.

  3. Daniel Lilly - Glad to hear about your points and miles. Enjoy Wisconsin and Illinois. You don't care one whit about financial discipline, which is why you will blast the "GOP". Classic liberalism.

  4. Isn't the real reason the terrain? The planners under-estimated the undulating terrain, sink holes, karst features, etc. This portion of the route was flawed from the beginning.

  5. You thought no Indy was bad, how's no fans working out for you? THe IRl No direct competition and still no fans. Hey George Family, spend another billion dollars, that will fix it.

ADVERTISEMENT